. Author manuscript; available in PMC: 2022 Mar 9.

Published in final edited form as: J Vasc Surg. 2019 Jan;69(1):156–163.e1. doi: 10.1016/j.jvs.2018.05.244

Table II.

Postoperative outcomes of bypass-first vs endovascular-first strategy

Characteristics	Bypass-first cohort	Endovascular-first cohort	P value
MALE	48 (9.0)	92 (11.2)	.19
Untreated loss of patency	10 (1.9)	17 (2.1)	.79
Major reintervention of treated arterial segment	23 (4.3)	25 (3.0)	.22
Transtibial or proximal amputation	23 (4.3)	61 (7.4)	.02
MACE	37 (6.9)	21 (2.6)	<.01
30-Day mortality	17 (3.2)	15 (1.8)	.10
MI or stroke	20 (3.7)	7 (0.9)	<.01
Other outcomes
Bleeding requiring transfusion or secondary procedure	130 (24.3)	59 (7.2)	<.01
Wound complication	52 (9.7)	30 (3.7)	<.01
Readmission	97 (18.2)	173 (21.1)	.19
Length of stay, days	11.87 ± 9.52	7.17 ± 11.60	<.01
Unplanned reoperation	102 (19.1)	141 (17.2)	.36

MACE, Major adverse cardiovascular event; MALE, major adverse limb event; MI, myocardial infarction.

Categorical variables are presented as number (%). Continuous variables are presented as mean ± standard deviation.